Items where authors include "Riva, N."

Article

Saez-Atienzar, S., Souza, C.D.S., Chia, R. et al. (323 more authors) (2024) Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data. Cell Genomics, 4 (11). 100679. ISSN 2666-979X

Currò, R., Dominik, N., Facchini, S. et al. (155 more authors) (2024) Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease. Brain, 147 (5). pp. 1887-1898. ISSN 0006-8950

Riva, N., Vella, K., Hickey, K. et al. (7 more authors) (2021) The effect of DOAC‐Stop® on several oral and parenteral anticoagulants. International Journal of Laboratory Hematology, 43 (4). O171-O175. ISSN 1751-5521

Gauer, J.S., Riva, N., Page, E.M. et al. (4 more authors) (2020) Effect of anticoagulants on fibrin clot structure: a comparison between vitamin K antagonists and factor Xa inhibitors. Research and Practice in Thrombosis and Haemostasis, 4 (8). pp. 1269-1281. ISSN 2475-0379

Riva, N., Borg Xuereb, C., Ageno, W. et al. (2 more authors) (2019) Validation and psychometric properties of the Maltese version of the Duke Anticoagulation Satisfaction Scale (DASS). Psychology Research and Behavior Management, 12. pp. 741-752.

Riva, N., Borg Xuereb, C., Makris, M. orcid.org/0000-0001-7622-7939 et al. (2 more authors) (2019) Reliability and validity of the Maltese version of the perception of anticoagulant treatment questionnaire (PACT-Q). Patient Preference and Adherence, Volume. pp. 969-979. ISSN 1177-889X

Riva, N., Vella, K., Meli, S. et al. (7 more authors) (2017) A comparative study using thrombin generation and three different INR methods in patients on vitamin K antagonist treatment. International Journal of Laboratory Hematology, 39 (5). pp. 482-488. ISSN 1751-5521

McLaughlin, R.L., Schijven, D., van Rheenen, W. et al. (433 more authors) (2017) Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications, 8. 14774.

Nardo, G., Trolese, M.C., de Vito, G. et al. (8 more authors) (2016) Immune response in peripheral axons delays disease progression in SOD1(G93A) mice. Journal of Neuroinflammation, 13 (1). p. 261. ISSN 1742-2094